Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1979-7-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0010-6178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:436413-ABO Blood-Group System,
pubmed-meshheading:436413-Blood Group Incompatibility,
pubmed-meshheading:436413-Blood Platelets,
pubmed-meshheading:436413-Blood Preservation,
pubmed-meshheading:436413-Blood Transfusion,
pubmed-meshheading:436413-HLA Antigens,
pubmed-meshheading:436413-Humans,
pubmed-meshheading:436413-Plateletpheresis,
pubmed-meshheading:436413-Thrombocytopenia
|
pubmed:year |
1979
|
pubmed:articleTitle |
Current status of platelet transfusion therapy.
|
pubmed:publicationType |
Journal Article
|